XML 16 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Adjustments to reconcile net income (loss) to net cash provided from operating activities:    
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ (405.9) $ 147.3
Depreciation and amortization 191.7 166.7
Deferred income taxes and investment tax credits, net (226.7) (1.9)
Equity in (earnings) losses of unconsolidated affiliates 719.6 [1] (66.5)
Distributions from unconsolidated affiliates 55.0 70.6
Allowance for equity funds used during construction (2.6) (2.7)
Stock-based compensation expense 4.3 5.9
Regulatory assets (6.1) (25.6)
Regulatory liabilities (26.7) (21.1)
Other assets 1.3 (3.2)
Other liabilities (15.6) 13.9
Change in certain current assets and liabilities:    
Accounts receivable and accrued unbilled revenues, net (35.8) (12.5)
Increase (Decrease) in Income Taxes Receivable 10.4 3.6
Fuel, materials and supplies inventories (1.5) 7.2
Fuel recoveries 71.9 (28.9)
Other current assets (10.8) (4.5)
Accounts payable (51.2) (83.4)
Other current liabilities (8.0) (36.1)
Net cash provided from operating activities 263.3 128.8
CASH FLOWS FROM INVESTING ACTIVITIES    
Capital expenditures (less allowance for equity funds used during construction) (280.8) (314.5)
Investment in unconsolidated affiliates (1.5) (3.2)
Net cash used in investing activities (282.3) (317.7)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from Issuance of Long-term Debt 297.2 295.9
Increase (decrease) in short-term debt (37.0) 207.5
Payment of long-term debt 0.0 (250.0)
Dividends paid on common stock (156.8) (148.6)
Net cash provided from financing activities 86.5 94.6
NET CHANGE IN CASH AND CASH EQUIVALENTS 67.5 (94.3)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 0.0 94.3
CASH AND CASH EQUIVALENTS AT END OF PERIOD 67.5 0.0
Proceeds from (Payments for) Other Financing Activities (7.2) (10.2)
Treasury Stock, Value, Acquired, Cost Method $ (9.7) $ 0.0
[1] In March 2020, the Company recorded a $780.0 million impairment on its investment in Enable, as further discussed in Notes 4 and 5.